AKT1 and cancer: These pathways, such as the PI3K/Akt/mTOR, AMPK, Wnt/β-Catenin, HIF, NF-κB, or MYC pathway, are often dysregulated, resulting in metabolic alterations that facilitate the growth and survival of cancer cells [191,192].